93 related articles for article (PubMed ID: 4366348)
1. [Behavior of intradialysis curves of the PRA (Plasma Renin Activity) in a group of uremic patients during a periodic hemodialysis treatment].
Farinelli A; Bagni B; Squerzanti R; Candini GC; Gilli P
Minerva Nefrol; 1973; 20(6):376-89. PubMed ID: 4366348
[No Abstract] [Full Text] [Related]
2. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
Cappelli G; Vagge R; Lamperi S
Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322
[No Abstract] [Full Text] [Related]
3. [Dopamine 17-beta-hydroxylase in chronic uremic patients under periodic hemodialytic treatment].
Cagossi M; Pigliucci GM; Ruvolo MR; Porcelli G
Chir Patol Sper; 1979 Dec; 27(6):579-89. PubMed ID: 400642
[No Abstract] [Full Text] [Related]
4. [Study of plasma renin activity in uremic patients undergoing periodic hemodialytic treatment].
Pigliucci GM; Suraci V; Alcini E
Chir Patol Sper; 1974 Apr; 22(2):89-97. PubMed ID: 4434788
[No Abstract] [Full Text] [Related]
5. [Study of the plasmatic renin and reno-medullin in chronic uremic patients during extracorporeal hemodialytic treatment].
Ripa R; Alvisi R; Salzano S; Baggioni GF
Minerva Med; 1970 Nov; 61(92):5219-33. PubMed ID: 4321215
[No Abstract] [Full Text] [Related]
6. [Importance of the sodium content of the dialytic fluid in periodic hemodialysis. Data on the behavior of arterial pressure, corporeal sodium pattern and the plasma renin activity in some hypertensive, chronic uremic patients treated with dialysis with a bath with varying sodium content].
Romagnoli GF; Huber W; Di Landro D; Bertoli M; Antonello A; Cerutti M; Chini M
Minerva Nefrol; 1975; 22(4-5):205-11. PubMed ID: 1207978
[No Abstract] [Full Text] [Related]
7. Plasma renin activity (PRA) in 89 patients on regular haemodialysis.
Craswell PW; Hird VM; Baillod RA; Ku G; Robertson JS; Varghese Z; Moorhead JF
Proc Eur Dial Transplant Assoc; 1972; 9():154-63. PubMed ID: 4359252
[No Abstract] [Full Text] [Related]
8. [Correlations between renin and hemodynamics in chronic uremic patients under periodic hemodialysis treatment].
Pigliucci GM; Ruvolo MR; Pozzetto U; Martino F; Magellano G; Cagossi M
Chir Patol Sper; 1979 Jun; 27(3):273-89. PubMed ID: 400403
[No Abstract] [Full Text] [Related]
9. [Clinical studies of hypertension in chronic glomerulonephritis. 2. Hypertension in the uremic phase: relationship between hemodynamic changes and plasma renin activity during hemodialysis].
Nishio I
Nihon Jinzo Gakkai Shi; 1974 Jan; 16(1):20-32. PubMed ID: 4471777
[No Abstract] [Full Text] [Related]
10. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
[No Abstract] [Full Text] [Related]
11. [Study of plasma renin activity in 40 subjects submitted to periodic hemodialysis].
Valdenaire JC; Martineaux C; de Talancé N; Kessler M; Huriet C; Boulangé M
J Urol Nephrol (Paris); 1976 Sep; 82(9):786-92. PubMed ID: 994295
[No Abstract] [Full Text] [Related]
12. [Changes of plasma renin activity and angiotensin II levels in women with polycystic ovary syndrome].
Li X; Shen H; Ge X
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):586-7. PubMed ID: 11372405
[TBL] [Abstract][Full Text] [Related]
13. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
14. [Application of radioimmunoanalysis of angiotensin I to the determination of plasma renin activity in humans].
Casado Pérez S; Gutiérrez Millet V; Hernando Avendaño L
Rev Clin Esp; 1973 Nov; 131(3):195-204. PubMed ID: 4358667
[No Abstract] [Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. [Antirenin activity of practolol in uremic subjects under hemodialysis treatment].
Splendiani G; Giammaria U; D'Alessandro V; Marinangeli G; De Meo F
Minerva Nefrol; 1975; 22(2-3):93-8. PubMed ID: 1226256
[No Abstract] [Full Text] [Related]
17. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
Lifshits NL; Kutyrina IM
Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
[TBL] [Abstract][Full Text] [Related]
18. Renin reactivity in normal, hypertensive, and uremic plasma.
Kotchen TA; Rice TW; Walters DR
J Clin Endocrinol Metab; 1972 Jun; 34(6):928-37. PubMed ID: 4336459
[No Abstract] [Full Text] [Related]
19. Renin, growth hormone and insulin in hemodialyzed uremic diabetics.
Avram MM
Artif Organs; 1978 Nov; 2(4):382-5. PubMed ID: 743011
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
Kotchen TA; Talwalkar RT; Kotchen JM; Miller MC; Welch WJ
Circ Res; 1975 Jun; 36(6 Suppl 1):17-27. PubMed ID: 1132076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
